KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 137 filers reported holding KRYSTAL BIOTECH INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $114,661,360 | -1.4% | 988,460 | -0.2% | 7.62% | +9.7% |
| Q2 2023 | $116,256,524 | +53.6% | 990,260 | +4.7% | 6.94% | +26.7% |
| Q1 2023 | $75,689,284 | -4.4% | 945,407 | -5.4% | 5.48% | +11.3% |
| Q4 2022 | $79,199,165 | +11.6% | 999,737 | -1.8% | 4.92% | -9.9% |
| Q3 2022 | $70,982,000 | -1.3% | 1,018,388 | -7.0% | 5.47% | -19.5% |
| Q2 2022 | $71,924,000 | +24.8% | 1,095,407 | +26.5% | 6.79% | +38.2% |
| Q1 2022 | $57,640,000 | – | 866,250 | – | 4.91% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 2,003,367 | $232,390,572 | 11.06% |
| Frazier Life Sciences Management, L.P. | 988,460 | $114,661,360 | 7.62% |
| S Squared Technology, LLC | 108,215 | $12,552,940 | 6.77% |
| Avoro Capital Advisors LLC | 2,565,555 | $297,604,380 | 4.64% |
| APIS CAPITAL ADVISORS, LLC | 24,000 | $2,784,000 | 3.61% |
| Nicholas Investment Partners, LP | 355,611 | $41,250,876 | 3.08% |
| Ghost Tree Capital, LLC | 80,000 | $9,280,000 | 3.05% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 71,531 | $8,297,596 | 2.52% |
| Affinity Asset Advisors, LLC | 57,500 | $6,670,000 | 1.88% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 46,092 | $5,344,828 | 1.80% |